The Intelligence from The Economist Granting immunity: America weighs vaccine approval
Dec 8, 2020
Natasha Loader, health policy editor at The Economist, discusses the U.S. vaccine approval process amidst the urgency of the pandemic, highlighting safety evaluations and distribution challenges. Sarah Burke, a foreign correspondent, explores the rise of multi-generational living as a solution to loneliness, showcasing innovative housing projects aimed at promoting community integration. The conversation expands to the evolution of Advent calendars, from traditional designs to extravagant modern versions, reflecting cultural shifts during the festive season.
AI Snips
Chapters
Transcript
Episode notes
First Vaccine Recipient
- 90-year-old Margaret Keenan was the first person outside clinical trials to receive the Pfizer vaccine in Britain.
- America awaits emergency authorization for the same vaccine.
US vs UK Vaccine Approval
- America prioritizes a thorough vaccine approval process, reanalyzing raw data.
- The UK uses a rolling review, accepting data as it becomes available.
Vaccination Priority
- Healthcare workers and long-term care residents will be prioritized for vaccination.
- Essential workers, high-risk individuals, and those over 65 will follow.